Bowen Ke

Dr. Bowen Ke


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2019 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
XJXingyue Ji
Xingyue Ji
ZPZhixiang Pan
Zhixiang Pan
BYBingchen Yu
Bingchen Yu
LCLadie Kimberly De La Cruz
Ladie Kimberly De La Cruz
YZYueqin Zheng
Yueqin Zheng
Binghe WangBinghe Wang
Binghe Wang
This review summarizes recent developments in using bioorthogonal chemistry in prodrug design for the delivery of traditional small molecule- and gasotransmitter-based therapeutics.

23 November 2016 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
XJXingyue Ji
Xingyue Ji
CZCheng Zhou
Cheng Zhou
KJKaili Ji
Kaili Ji
RARobert E. Aghoghovbia
Robert E. Aghoghovbia
ZPZhixiang Pan
Zhixiang Pan
Binghe WangBinghe Wang
Binghe Wang

7 December 2015 in Analytical Chemistry
Verified
Journal Article
Closed access
BKBowen Ke
Bowen Ke
WWWenxiao Wu
Wenxiao Wu
WLWei Liu
Wei Liu
HLHong Liang
Hong Liang
DGDeying Gong
Deying Gong
MLMinyong Li
Minyong Li

23 May 2016 in Analytical Chemistry
Verified
Journal Article
Closed access
PFPing Feng
Ping Feng
HZHuateng Zhang
Huateng Zhang
QDQuankun Deng
Quankun Deng
WLWei Liu
Wei Liu
LYLinghui Yang
Linghui Yang
MLMinyong Li
Minyong Li

28 February 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
XJXingyue Ji
Xingyue Ji
ZPZhixiang Pan
Zhixiang Pan
CLChunjie Li
Chunjie Li
TKTing Kang
Ting Kang
LCLadie Kimberly C. De La Cruz
Ladie Kimberly C. De La Cruz
Binghe WangBinghe Wang
Binghe Wang

1 September 2021 in Journal of Advanced Research
Verified
Journal Article
Open access
LWLian Wang
Lian Wang
XXXin Xie
Xin Xie
BKBowen Ke
Bowen Ke
WHWei Huang
Wei Huang
XJXian Jiang
Xian Jiang
GHGu He
Gu He
Endogenous gasotransmitters are small gaseous mediators that can be generated endogenously by mammalian organisms. The dysregulation of the gasotransmitter system is associated with numerous disorders ranging from inflammatory diseases to cancers. However, the relevance of these endogenous gasotransmitters, prodrug donors and inhibitors in inflammatory dermatological disorders has not yet been thoroughly reviewed and discussed. This review discusses the recent progress and will provide perspectives on endogenous gasotransmitters in the context of inflammatory dermatological disorders. Endogenous gasotransmitters nitric oxide (NO), carbon monoxide (CO) and hydrogen sulfide (H2S) are signaling molecules that regulate several physiological and pathological processes. In addition, sulfur dioxide (SO₂), methane (CH4), hydrogen gas (H2), ammonia (NH3), and carbon dioxide (CO2) can also be generated endogenously and may take part in physiological and pathological processes. These signaling molecules regulate inflammation, vasodilation, and oxidative stress, offering therapeutic potential and attracting interest in the field of inflammatory dermatological disorders including psoriasis, atopic dermatitis, acne, rosacea, and chronic skin ulcers. The development of effective gas donors and inhibitors is a promising alternative to treat inflammatory dermatological disorders with controllable and precise delivery in the future.